Testosterone Replacement Therapy in Men With Type 2 Diabetes Mellitus and Low Testosterone Levels
Phase of Trial: Phase II/III
Latest Information Update: 30 Jun 2014
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 12 Jun 2012 Planned end date changed from 1 Sep 2012 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 24 Jan 2009 Additional trial centre identified as reported by ClinicalTrials.gov, last updated 16-01-2009
- 16 Jan 2009 Actual initiation date changed from May 2008 to Jan 2009 as reported by ClinicalTrials.gov.